# Somasekar Seshagiri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/somasekar-seshagiri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,760 |
| Field | Ferroptosis and cancer prognosis |
| h-index | 68 |
| i10-index | 109 |
| Last Known Institution | Sarepta Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5088898639 |
| ORCID iD | https://orcid.org/0000-0003-4272-6443 |
| Works | 252 |

## Researcher papers

- [Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer](https://scholariq.org/papers/comprehensive-genomic-analysis-identifies-sox2-as-a-frequently-amplified-gene-in/)
- [Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin](https://scholariq.org/papers/evidence-for-sequenced-molecular-evolution-of-i-idh1-i-mutant-glioblastoma-from/)

## Researcher topics

- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Single-cell and spatial transcriptomics](https://scholariq.org/topics/single-cell-and-spatial-transcriptomics/)
- [Genomics and Rare Diseases](https://scholariq.org/topics/genomics-and-rare-diseases/)

## Researcher university

- [Sarepta Therapeutics (United States)](https://scholariq.org/institutions/sarepta-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
